The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 |
doi: 10.3389/fimmu.2024.1478201
This article is part of the Research Topic Identification and Characterization of Neoantigens for Cancer Immunotherapy View all 8 articles
LRMAHpan: a novel tool for multi-allelic HLA presentation prediction using Resnet-based and LSTM-based neural networks
Provisionally accepted- 1 Southeast University, Nanjing, China
- 2 Guangzhou University, Guangzhou, Guangdong Province, China
- 3 Zhongda Hospital, Southeast University, Nanjing, Jiangsu Province, China
The identification of peptides eluted from HLA complexes by mass spectrometry (MS) can provide critical data for deep learning models of antigen presentation prediction and promote neoantigen vaccine design. However, a significant challenge for current prediction approaches is determining which HLA allele eluted peptides inherit. Here, we present a tool for prediction of multiple allele (MA) presentation called LRMAHpan, which integrates LSTM network and ResNet_CA network for antigen processing and presentation prediction. We trained and tested the LRMAHpan BA (binding affinity) and the LRMAHpan AP (antigen processing) models using mass spectrometry data, subsequently combined them into the LRMAHpan PS (presentation score) model. Our approach is based on a novel pHLA encoding method that enables the integration of neoantigen prediction tasks into computer vision methods. This method aggregates MA data into a multichannel matrix and incorporates peptide sequences to efficiently capture binding signals. LRMAHpan significantly outperforms standard predictors such as NetMHCpan 4.1, MHCflurry 2.0, and TransPHLA in terms of positive predictive value (PPV) when applied to MA data. Additionally, it can accommodate peptides of variable lengths and predict HLA class I and II presentation.We also predicted neoantigens in a cohort of metastatic melanoma patients, identifying several shared neoantigens.
Keywords: Biomedical Engineering, Neoantigen prediction, deep learning, Multi allelic HLA, MHC, antigen processing
Received: 09 Aug 2024; Accepted: 30 Oct 2024.
Copyright: © 2024 Mi, Li, Ye, Dai, Ding, Sun, Xiao and Yang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Shaohao Li, Southeast University, Nanjing, China
Zhu Dai, Southeast University, Nanjing, China
Bo Sun, Southeast University, Nanjing, China
Zhongdang Xiao, Southeast University, Nanjing, China
Shen Yang, Zhongda Hospital, Southeast University, Nanjing, 210009, Jiangsu Province, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.